BIOSTAR PHARM-B(02563): Expected audit reservation opinion

13:18 25/03/2026

Huahao Zhongtian Pharmaceuticals-B (02563) issued an announcement, the board of directors of the company hereby notifies the shareholders and potential investors that, during the audit of the comprehensive financial statements for the year ended December 31, 2025, the company's auditor indicated that they are expected to issue a qualified opinion in the audit report.

BIOSTAR PHARM-B (02563) Announces that during the review of the comprehensive financial statements for the year ended December 31, 2025, the company's auditors have indicated that they expect to issue a qualified opinion in their audit report. The company's board of directors hereby informs its shareholders and potential investors of this matter.

HK Stock Market Move | CSPC PHARMA (01093) rose more than 3%. Net profit fell by 10% year-on-year. Annual dividends increased by 11.5% year-on-year.

Citigroup: CHINA OILFIELD (02883) Achieved Performance in Line with Expectations, Rated "Buy"

HK Stock Market Move | HUABAO INTL (00336) surged more than 11% in the afternoon. Institutions pointed out that exploding beads and HNB films overseas orders are expected to quickly increase.

HK Stock Market Move | CSPC PHARMA (01093) rose more than 3%. Net profit fell by 10% year-on-year. Annual dividends increased by 11.5% year-on-year.

Citigroup: CHINA OILFIELD (02883) Achieved Performance in Line with Expectations, Rated "Buy"

HK Stock Market Move | HUABAO INTL (00336) surged more than 11% in the afternoon. Institutions pointed out that exploding beads and HNB films overseas orders are expected to quickly increase.